Patients with certain congenital heart disease, which disrupt blood flow from the heart to the lungs, may have previously had multiple open-heart surgeries over the course of their lifetime. Osamah Aldoss, MBBS, UI clinical associate professor of pediatrics-cardiology, says the Harmony valve, recently approved by the Food and Drug Administration (FDA), offers these patients not only a less invasive treatment than open-heart surgery, but also one with less recovery time and fewer restrictions before returning to work or other activities.